Dauricine
Names | |
---|---|
Preferred IUPAC name
(11R,71R)-16,17,76,77-Tetramethoxy-12,72-dimethyl-11,12,13,14,71,72,73,74-octahydro-4-oxa-1,7(1)-diisoquinolina-3(1,3),5(1,4)-dibenzenaheptaphan-34-ol | |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.208.622 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C38H44N2O6 | |
Molar mass | 624.778 g·mol−1 |
Density | 1.186 g/mL |
Melting point | 115 °C |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Dauricine is a plant
Bischler-Napieralski reaction to do so.[3] Dauricine has been studied in vitro for its potential to inhibit cancer cell growth[4][5][6][7] and to block cardiac transmembrane Na+, K+, and Ca2+ ion currents.[8]
References
- ^ "CHEBI:4331 - dauricine". ChEBI. Retrieved 30 May 2015.
- .
- ISBN 9780080865331. Retrieved 30 May 2015.
- S2CID 5501319.
- S2CID 21824941.
- PMID 19349962.
- PMID 23199717.
- PMID 12466045.